# Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation

> **NCT00186420** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 13 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Taxotere

## Key facts

- **NCT ID:** NCT00186420
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2006-01
- **Final completion:** 2009-09
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00186420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00186420, "Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00186420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*